Description
An ELISA test that measures neutralizing antibodies against the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Used to assess immunity after vaccination or infection, particularly in individuals at risk of severe COVID-19.
This lab test includes home sample collection via a provided kit or by a clinician, and you'll receive a comprehensive physical health report with your results.